First Header Logo Second Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
PropertyValue
has major subject area list Antibodies, Monoclonal; Hematopoietic Stem Cell Transplantation; Lymphoma, Non-Hodgkin; Salvage Therapy
information resource reference Kaya H, Keung YK, Case D, Cruz JM, Perry JJ, Radford JE, Hurd DD. Efficacy and safety of monoclonal anti-CD20 antibody (rituximab) for the treatment of patients with recurrent low-grade non-Hodgkin's lymphoma after high-dose chemotherapy and autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2002; 8(10):544-9.
label Efficacy and safety of monoclonal anti-CD20 antibody (rituximab) for the treatment of patients with recurrent low-grade non-Hodgkin's lymphoma after high-dose chemotherapy and autologous hematopoietic cell transplantation.
Search Criteria
  • Non Hodgkin Lymphoma